Access Statistics for Matthew J. Higgins

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Country‑Specific View of Tariffs 0 1 14 14 2 5 25 25
Accounting for Price Endogeneity in Airline Itinerary Choice Models: An Application to Continental U.S. Markets 0 0 0 46 2 4 13 97
Assets with "Warts": How Reliable is the Market for Technology? 0 0 0 8 2 2 4 42
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 16 3 5 12 88
Black Populations and Economic Growth: An Extreme Bounds Analysis of Mississippi County-Level Data 0 0 0 37 0 0 12 268
Blockbusters, Sequels and the Nature of Innovation 0 0 14 14 2 3 36 36
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology 0 0 0 34 2 3 11 232
Corporate Venture Capital as a Real Option in the Markets for Technology 0 1 1 72 2 5 12 113
Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks 0 0 1 18 3 6 14 38
Explaining Preferences for Control Rights in Strategic Alliances: A Property Rights and Capabilities Perspective Approach 0 0 0 29 2 3 12 89
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 47 0 1 13 376
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 61 3 7 15 438
Federal, State, and Local Governments:Evaluating their Separate Roles in US Growth 0 0 0 12 1 5 11 153
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 0 4 0 2 17 52
Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation 0 1 2 42 2 4 27 122
Growth and Convergence across the U.S: Evidence from County-Level Data 0 0 1 255 1 6 27 788
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 204 1 4 22 643
Growth and Convergence across the US: Evidence from County-Level Data 0 0 1 15 1 1 14 186
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 7 2 9 19 116
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 2 2 2 15 34
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 209 2 3 10 1,138
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 2 0 5 10 106
Heterogeneous Convergence 0 0 0 39 1 4 16 350
Heterogeneous Convergence 0 0 0 14 5 10 25 117
Heterogeneous Convergence 0 0 0 57 1 3 13 217
Heterogeneous Convergence 0 0 0 15 2 7 21 114
Heterogeneous convergence 0 0 0 2 1 1 14 42
Intra-alliance performance, control rights, and today's split of tomorrow's value 0 0 0 85 0 0 10 235
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 0 11 0 0 10 128
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 1 426 3 4 21 3,828
Market Size and Research: Evidence from the Pharmaceutical Industry 0 0 0 17 2 3 8 61
Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms 0 1 1 43 2 6 12 73
Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data 0 0 0 1 2 2 7 19
Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry 0 1 1 58 4 6 19 287
Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak 0 0 0 2 4 6 14 30
Robust Correlates of County-Level Growth in the U.S 0 0 1 40 1 1 16 187
Robust correlates of county-level growth in the United States 0 0 0 0 1 1 7 19
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 30 1 2 12 137
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data (revised version) 0 0 0 36 3 5 9 136
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 1 1 1 10 30
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 151 0 5 16 545
Sigma-Convergence Versus Beta-Convergence: Evidence from U.S. County-Level Data 0 0 0 522 1 3 8 1,671
Stronger IPR, Better Inclusion? Impact Of WTO Accession On Female AI Inventors in China 0 0 2 14 0 5 13 49
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 56 6 6 14 168
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 46 3 3 15 125
The Effect of Contractual Complexity on Technology Sourcing Agreements 0 0 0 40 1 2 4 264
The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry 0 0 0 120 2 5 11 402
The Role of Assets In Place: Loss of Market Exclusivity and Investment 0 0 0 11 2 4 16 51
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 0 0 14 1 2 8 57
Why Investment‑Led Growth Lowers Chinese Living Standards 1 2 4 19 4 10 27 39
Will Peak Demand Roil Global Oil Markets? 0 1 4 4 1 5 11 11
Total Working Papers 1 8 48 3,022 90 197 738 14,572


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accounting for price endogeneity in airline itinerary choice models: An application to Continental U.S. markets 0 1 3 10 3 11 21 93
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 6 4 6 22 75
Conveying quality and value in emerging industries: Star scientists and the role of signals in biotechnology 0 0 0 24 3 8 26 180
Corporate venture capital as a real option in the markets for technology 0 0 0 6 3 10 27 69
Evaluating the effects of Small Business Administration lending on growth 0 1 5 16 6 16 32 97
Federal, State, and Local Governments: Evaluating Their Separate Roles in US Growth 0 0 1 2 1 3 17 42
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 0 32 1 1 14 195
Generic competition and the incentives for early-stage pharmaceutical innovation 0 0 3 7 3 5 22 37
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 4 0 4 11 41
Growth and Convergence across the United States: Evidence from County-Level Data 1 1 2 155 7 9 25 440
Heterogeneous Convergence 0 0 0 3 3 8 18 48
Heterogeneous convergence 0 0 0 40 1 2 16 154
How Reliable Is the Market for Technology? 0 0 0 14 1 3 9 80
Modeling competition among airline itineraries 0 0 2 13 2 6 17 69
Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data 0 0 0 0 0 1 7 7
Productivity and the role of complementary assets in firms' demand for technology innovations 0 0 0 23 4 7 16 125
Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry 0 0 0 11 6 7 11 85
Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak 0 0 0 0 2 5 16 20
Robust Correlates of County-Level Growth in the U.S 0 0 0 0 4 4 15 64
Robust correlates of county-level growth in the United States 0 0 0 11 1 1 6 56
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 293 1 3 10 1,188
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 4 11 5 10 29 64
Sigma Convergence versus Beta Convergence: Evidence from U.S. County‐Level Data 0 0 1 10 5 9 19 57
Strategic Alliances: Trading Ownership for Capabilities 0 0 0 8 3 5 15 55
The allocation of control rights in pharmaceutical alliances 0 0 0 60 1 1 3 168
The balance of payments crisis in the euro area periphery 0 0 2 180 2 5 28 721
The impact of advance purchase deadlines on airline consumers’ search and purchase behaviors 0 0 1 8 2 4 11 66
The outsourcing of R&D through acquisitions in the pharmaceutical industry 0 1 6 375 1 5 27 1,049
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 0 1 4 7 8 15 32
Total Journal Articles 1 4 31 1,326 82 167 505 5,377


Statistics updated 2026-05-06